您的位置: 首页 > 农业专利 > 详情页

COMBINATION THERAPY OF T CELL ACTIVATING BISPECIFIC ANTIGEN BINDING MOLECULES AND PD-1 AXIS BINDING ANTAGONISTS
专利权人:
Hoffmann-La Roche Inc.
发明人:
Christian Klein,Vaios Karanikas,Pablo Umana,Alfred Zippelius,Daniela Thommen,Jens Schreiner
申请号:
US15600011
公开号:
US20170349666A1
申请日:
2017.05.19
申请国别(地区):
US
年份:
2017
代理人:
摘要:
The present invention generally relates to T cell activating bispecific antigen binding molecules, PD-1 axis binding antagonists, and in particular to combination therapies employing such T cell activating bispecific antigen binding molecules and PD-1 axis binding antagonists, and their use of these combination therapies for the treatment of cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充